UB Paderborn / Katalog / Suche / in CDI

Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials

Clinical infectious diseases, 2014-08, Vol.59 (3), p.345-354

2014

Link zum Volltext

Verfügbarkeit prüfen

Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy

PloS one, 2012-11, Vol.7 (11), p.e49006

2012

Link zum Volltext

Verfügbarkeit prüfen

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2010-03, Vol.375 (9719), p.998-1006

2010

Link zum Volltext

Verfügbarkeit prüfen

Decrease in Thoracic Vertebral Bone Attenuation With Calcium‐Based Phosphate Binders in Hemodialysis

Journal of bone and mineral research, 2005-05, Vol.20 (5), p.764-772

2005

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Tolerability of Sevelamer Carbonate in Hyperphosphatemic Patients Who Have Chronic Kidney Disease and Are Not on Dialysis

Clinical journal of the American Society of Nephrology, 2008-07, Vol.3 (4), p.1125-1130

2008

Link zum Volltext

Verfügbarkeit prüfen

Tolevamer, a Novel Nonantibiotic Polymer, Compared with Vancomycin in the Treatment of Mild to Moderately Severe Clostridium difficile–Associated Diarrhea

Clinical infectious diseases, 2006-08, Vol.43 (4), p.411-420

2006

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Parallel, Open-Label Study to Compare Once-Daily Sevelamer Carbonate Powder Dosing With Thrice-Daily Sevelamer Hydrochloride Tablet Dosing in CKD Patients on Hemodialysis

American journal of kidney diseases, 2010-02, Vol.55 (2), p.307-315

2010

Link zum Volltext

Verfügbarkeit prüfen

Reproducibility and Validity of a Self-Administered Physical Activity Questionnaire for Male Health Professionals

Epidemiology (Cambridge, Mass.), 1996-01, Vol.7 (1), p.81-86

1996

Link zum Volltext

Verfügbarkeit prüfen

Cardiac calcification in adult hemodialysis patients: A link between end-stage renal disease and cardiovascular disease?

Journal of the American College of Cardiology, 2002-02, Vol.39 (4), p.695-701

2002

Link zum Volltext

Verfügbarkeit prüfen

Determinants of progressive vascular calcification in haemodialysis patients

Nephrology, dialysis, transplantation, 2004-06, Vol.19 (6), p.1489-1496

2004

Link zum Volltext

Verfügbarkeit prüfen

Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients

The American heart journal, 2005-05, Vol.149 (5), p.820-825

2005

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein B Synthesis Inhibition by Mipomersen Reduces LDL-C When Added to Maximally Tolerated Lipid-Lowering Medication in Patients with Severe Heterozygous Hypercholesterolemia

Journal of clinical lipidology, 2011-05, Vol.5 (3), p.219-220

2011

Link zum Volltext

Verfügbarkeit prüfen

Reproducibility of a Self-administered Lifetime Physical Activity Questionnaire among Female College Alumnae

American journal of epidemiology, 2002-02, Vol.155 (3), p.282-291

2002

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis

Nephrology, dialysis, transplantation, 2009-01, Vol.24 (1), p.278-285

2009

Link zum Volltext

Verfügbarkeit prüfen

Effects of sevelamer and calcium‐based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: A randomized clinical trial

Arthritis and rheumatism, 2005-01, Vol.52 (1), p.290-295

2005

Link zum Volltext

Verfügbarkeit prüfen

Quality of Care by Race and Gender for Congestive Heart Failure and Pneumonia

Medical care, 1999-12, Vol.37 (12), p.1260-1269

1999

Link zum Volltext

Verfügbarkeit prüfen

Validity and reproducibility of a physical activity questionnaire in women

Medicine and science in sports and exercise, 2002-06, Vol.34 (6), p.987-992

2002

Link zum Volltext

Verfügbarkeit prüfen

Hospital Readmissions and Quality of Care

Medical care, 1999-05, Vol.37 (5), p.490-501

1999

Link zum Volltext

Verfügbarkeit prüfen

Quality of care for two common illnesses in teaching and nonteaching hospitals

Health affairs (Millwood, Va.), 1998-11, Vol.17 (6), p.194-205

1998

Link zum Volltext

Verfügbarkeit prüfen

APOLIPOPROTEIN B SYNTHESIS INHIBITION BY MIPOMERSEN REDUCES LOW-DENSITY LIPOPROTEIN CHOLESTEROL WHEN ADDED TO MAXIMALLY TOLERATED LIPID-LOWERING MEDICATION IN PATIENTS WITH SEVERE HETEROZYGOUS HYPERCHOLESTEROLEMIA

Journal of the American College of Cardiology, 2011-04, Vol.57 (14), p.E492-E492

2011

Link zum Volltext

Verfügbarkeit prüfen

Treatment of rheumatoid arthritis with oral type II collagen: Results of a multicenter, double‐blind, placebo‐controlled trial

Arthritis and rheumatism, 1998-02, Vol.41 (2), p.290-297

1998

Link zum Volltext

Verfügbarkeit prüfen

The validity of self-reported health-care utilization by AIDS patients

AIDS (London), 1996-06, Vol.10 (7), p.775-784

1996

Link zum Volltext

Verfügbarkeit prüfen

48

American journal of kidney diseases, 2007-04, Vol.49 (4), p.B36-B36

2007

Link zum Volltext

Verfügbarkeit prüfen

48: A Randomized, Double-Blind, Cross-Over Design Study of Sevelamer Hydrochloride (SH, Renagel ®) and Sevelamer Carbonate (SC) in Chronic Kidney Disease Patients on Hemodialysis

American journal of kidney diseases, 2007, Vol.49 (4), p.B36-B36

2007

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Umbilical Cord Collection Methods: Impact on Cellularity and Microbial Contamination Rates

Blood, 2005-11, Vol.106 (11), p.5279-5279

2005

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials

Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

Decrease in Thoracic Vertebral Bone Attenuation With Calcium‐Based Phosphate Binders in Hemodialysis

Efficacy and Tolerability of Sevelamer Carbonate in Hyperphosphatemic Patients Who Have Chronic Kidney Disease and Are Not on Dialysis

Tolevamer, a Novel Nonantibiotic Polymer, Compared with Vancomycin in the Treatment of Mild to Moderately Severe Clostridium difficile–Associated Diarrhea

A Randomized, Parallel, Open-Label Study to Compare Once-Daily Sevelamer Carbonate Powder Dosing With Thrice-Daily Sevelamer Hydrochloride Tablet Dosing in CKD Patients on Hemodialysis

Reproducibility and Validity of a Self-Administered Physical Activity Questionnaire for Male Health Professionals

Cardiac calcification in adult hemodialysis patients: A link between end-stage renal disease and cardiovascular disease?

Determinants of progressive vascular calcification in haemodialysis patients

Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients

Apolipoprotein B Synthesis Inhibition by Mipomersen Reduces LDL-C When Added to Maximally Tolerated Lipid-Lowering Medication in Patients with Severe Heterozygous Hypercholesterolemia

Reproducibility of a Self-administered Lifetime Physical Activity Questionnaire among Female College Alumnae

Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis

Effects of sevelamer and calcium‐based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: A randomized clinical trial

Quality of Care by Race and Gender for Congestive Heart Failure and Pneumonia

Validity and reproducibility of a physical activity questionnaire in women

Hospital Readmissions and Quality of Care

Quality of care for two common illnesses in teaching and nonteaching hospitals

APOLIPOPROTEIN B SYNTHESIS INHIBITION BY MIPOMERSEN REDUCES LOW-DENSITY LIPOPROTEIN CHOLESTEROL WHEN ADDED TO MAXIMALLY TOLERATED LIPID-LOWERING MEDICATION IN PATIENTS WITH SEVERE HETEROZYGOUS HYPERCHOLESTEROLEMIA

Treatment of rheumatoid arthritis with oral type II collagen: Results of a multicenter, double‐blind, placebo‐controlled trial

The validity of self-reported health-care utilization by AIDS patients

48

48: A Randomized, Double-Blind, Cross-Over Design Study of Sevelamer Hydrochloride (SH, Renagel ®) and Sevelamer Carbonate (SC) in Chronic Kidney Disease Patients on Hemodialysis

Comparison of Umbilical Cord Collection Methods: Impact on Cellularity and Microbial Contamination Rates

Suchergebnisse filtern